hydroxyindoleacetic acid has been researched along with phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JC; Huang, YK; Li, JY; Liang, KW | 1 |
1 other study(ies) available for hydroxyindoleacetic acid and phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide
| Article | Year |
|---|---|
Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Dopamine; Drug Synergism; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Motor Activity; Narcotic Antagonists; Neurotransmitter Agents; Nucleus Accumbens; Oligopeptides; Prefrontal Cortex; Random Allocation; Rats; Rats, Sprague-Dawley; Serotonin; Substance-Related Disorders | 1999 |